Welcome to our dedicated page for Adtalem Global Ed news (Ticker: ATGE), a resource for investors and traders seeking the latest updates and insights on Adtalem Global Ed stock.
Adtalem Global Education operates a portfolio of specialized institutions serving healthcare and professional education markets, making its news coverage relevant for investors tracking enrollment trends, regulatory developments, and institutional partnerships. The company's news typically reflects developments across multiple educational brands operating in distinct market segments.
Earnings announcements reveal enrollment patterns across nursing, medical, veterinary, and professional certification programs. Since tuition represents the primary revenue source, enrollment trends directly impact financial performance. Quarterly reports often discuss segment performance, showing how different institutions contribute to overall results and highlighting growth or contraction in specific program areas.
Partnership announcements indicate strategic positioning within healthcare education. Collaborations with healthcare systems create clinical training opportunities essential for nursing and medical programs. Technology partnerships affect educational delivery capabilities and online program expansion. These relationships influence the company's ability to scale programs and maintain accreditation requirements for clinical placements.
Regulatory and accreditation news carries significant weight for Adtalem. Changes to federal student aid policies, accreditation standards, or state licensing requirements affect operational parameters. For-profit education faces ongoing regulatory scrutiny around student outcomes and debt loads, making compliance-related announcements material to understanding the operating environment.
Executive appointments and organizational changes reflect strategic priorities. Leadership shifts in individual institutions or at the corporate level can signal operational adjustments or strategic pivots. Management commentary during earnings calls provides context on competitive positioning, enrollment initiatives, and responses to industry trends affecting healthcare workforce demand.
This news coverage helps investors understand how enrollment cycles, regulatory changes, healthcare workforce dynamics, and educational delivery innovations affect a multi-institutional education company operating across diverse program types and geographic markets.
Adtalem Global Education (NYSE: ATGE) will release second quarter fiscal 2026 results on Wednesday, Jan. 28, 2026 after market close.
The company will host a conference call the same day at 4:00 p.m. CT (5:00 p.m. ET) to discuss results. U.S. dial-in is +1 877-407-6184; international dial-in is +1 201-389-0877; state the prompt "Adtalem earnings call" or use conference ID 13757746. The call will be simulcast and archived on the Adtalem investor relations website with a replay available for 30 days via dial-in or the investor site.
Adtalem (NYSE: ATGE) completed a $150 million accelerated share repurchase, buying ~1.6 million shares, and its Board approved a new $750 million share repurchase authorization through December 2028. Since February 2022 the company has returned $913 million by repurchasing 17.2 million shares at an average price of $52.95, reducing shares outstanding by 30% from the Feb. 1, 2022 base. Adtalem reported 34.9 million shares outstanding as of Dec. 10, 2025 and reduced debt by $1.1 billion to $508.4 million as of Oct. 31, 2025.
The company said repurchases may occur via open market or negotiated transactions, subject to SEC rules and market conditions, and noted an Investor Day on Feb. 24, 2026.
Adtalem Global Education (NYSE: ATGE) said it will accelerate execution of its remaining $136 million under a previously authorized $150 million share repurchase program, with repurchases permitted through May 2028. The company reported Q1 enrollment +8% YoY and Q1 revenue +10.8% YoY, and reaffirmed fiscal year 2026 guidance: revenue $1,900M–$1,940M (≈6.0%–8.5% growth) and adjusted EPS $7.60–$7.90 (≈14.0%–18.5% growth). An Investor Day is scheduled for February 24, 2026.
Adtalem Global Education (NASDAQ:ATGE) is expanding pathways into medical school to help address a projected global health workforce shortfall. Key initiatives include Advanced Medical Preparation (AMP) India feeding into Ross University School of Medicine in Barbados, a guaranteed-admission route from a two-year accelerated BSc at University of Wolverhampton into American University of the Caribbean, and a U.S. partnership with ScribeAmerica offering conditional acceptances plus layered scholarship support.
The schools reported a 95% first-time residency attainment rate (2024-25). The ScribeAmerica pathway is open to ~10,000 eligible employees with no participation cap.
Adtalem Global Education (NYSE: ATGE) and Google Cloud announced a strategic partnership to launch a scalable AI credentials program for healthcare professionals, beginning in 2026. The curriculum will use Google Cloud AI technologies including Gemini and Vertex AI and aims to train students and practicing clinicians across Adtalem institutions that collectively serve over 91,000 students. The program covers clinical AI applications, ethics, patient safety, and hands-on tool experience, and will be offered as continuing education with flexible coursework for working clinicians.
Adtalem Global Education (NYSE:ATGE), America's leading healthcare educator, has scheduled its first quarter fiscal 2026 earnings release for October 30, 2025, after market close. The company will host a conference call at 4:00 p.m. CT (5:00 p.m. ET) to discuss the results.
Participants can join via phone using the toll-free number for U.S. callers or international line, or access the simulcast through Adtalem's investor relations website. A 30-day replay will be available through both phone and web platforms.
Adtalem Global Education (NYSE:ATGE), the leading healthcare educator in the United States, has announced its participation in two upcoming investor conferences in September 2025. CFO Bob Phelan will attend the 18th Annual Barrington Research Virtual Fall Investment Conference on September 16 for one-on-one investor meetings. Additionally, CEO Steve Beard and Phelan will present at the Jefferies Healthcare Services Conference in Nashville on September 30 at 1:50 p.m. CT. The Jefferies presentation will be available via live webcast and replay on Adtalem's investor relations website.
Adtalem Global Education (NYSE:ATGE) reported exceptional fiscal year 2025 results, with revenue increasing 12.9% year-over-year to $1.79 billion. The company achieved significant growth across all segments, with total enrollment up 10.2% YoY in Q4 2025.
Key highlights include adjusted EPS of $6.67 (up 33.1% YoY), adjusted EBITDA of $459.7 million (up 21.8% YoY), and record enrollments at Chamberlain (40,500+ students) and Walden (48,500+ students). The company demonstrated strong capital allocation, repurchasing $211 million of shares and maintaining a healthy net leverage ratio of 0.8x.
Looking ahead, Adtalem provided FY2026 guidance with revenue projected between $1.9-$1.94 billion and adjusted EPS of $7.60-$7.90, representing growth of 6.0-8.5% and 14.0-18.5% respectively.
Sallie Mae (NASDAQ:SLM) and Adtalem Global Education (NYSE:ATGE) have signed a Letter of Intent to develop alternative student financing solutions ahead of the federal Grad PLUS loan program phase-out in July 2026. The initiative aims to support healthcare students across Adtalem's five institutions, which serve over 90,000 students.
The partnership comes amid significant healthcare workforce shortages, with projections showing a physician deficit of up to 124,000 by 2034 and over 7,000 areas designated as Health Professional Shortage Areas. The companies plan to create tailored financing solutions with deferred repayment options and degree-specific terms, with final agreements expected in the coming months.
FAQ
What is the current stock price of Adtalem Global Ed (ATGE)?
What is the market cap of Adtalem Global Ed (ATGE)?
